Anti-POMGNT1 monoclonal antibody

Pre-made anti-POMGNT1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to POMGNT1/POMGNT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1427-Ab-1/ GM-Tg-hg-IP1427-Ab-2Anti-Human POMGNT1 monoclonal antibodyHuman
GM-Tg-rg-IP1427-Ab-1/ GM-Tg-rg-IP1427-Ab-2Anti-Rat POMGNT1 monoclonal antibodyRat
GM-Tg-mg-IP1427-Ab-1/ GM-Tg-mg-IP1427-Ab-2Anti-Mouse POMGNT1 monoclonal antibodyMouse
GM-Tg-cynog-IP1427-Ab-1/ GM-Tg-cynog-IP1427-Ab-2Anti-Cynomolgus/ Rhesus macaque POMGNT1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1427-Ab-1/ GM-Tg-felg-IP1427-Ab-2Anti-Feline POMGNT1 monoclonal antibodyFeline
GM-Tg-cang-IP1427-Ab-1/ GM-Tg-cang-IP1427-Ab-2Anti-Canine POMGNT1 monoclonal antibodyCanine
GM-Tg-bovg-IP1427-Ab-1/ GM-Tg-bovg-IP1427-Ab-2Anti-Bovine POMGNT1 monoclonal antibodyBovine
GM-Tg-equg-IP1427-Ab-1/ GM-Tg-equg-IP1427-Ab-2Anti-Equine POMGNT1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1427-Ab-1/ GM-Tg-hg-IP1427-Ab-2; GM-Tg-rg-IP1427-Ab-1/ GM-Tg-rg-IP1427-Ab-2;
GM-Tg-mg-IP1427-Ab-1/ GM-Tg-mg-IP1427-Ab-2; GM-Tg-cynog-IP1427-Ab-1/ GM-Tg-cynog-IP1427-Ab-2;
GM-Tg-felg-IP1427-Ab-1/ GM-Tg-felg-IP1427-Ab-2; GM-Tg-cang-IP1427-Ab-1/ GM-Tg-cang-IP1427-Ab-2;
GM-Tg-bovg-IP1427-Ab-1/ GM-Tg-bovg-IP1427-Ab-2; GM-Tg-equg-IP1427-Ab-1/ GM-Tg-equg-IP1427-Ab-2
Products NameAnti-POMGNT1 monoclonal antibody
Formatmab
Target NamePOMGNT1
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-POMGNT1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1427-Ag-1Recombinant multi-species PMGT1/ POMGNT1/ GNTI.2 protein


    Target information

    Target IDGM-IP1427
    Target NamePOMGNT1
    Gene ID55624,68273,362567,707205,482511,101094034,506551,100052003
    Gene Symbol and Synonyms0610016I07Rik,4930467B06Rik,GnT I.2,gnT-I.2,GNTI.2,LGMD2O,LGMDR15,MEB,MGAT1.2,POMGNT1,RP76
    Uniprot AccessionQ8WZA1,Q5XIN7,Q5EAB6
    Uniprot Entry NamePMGT1_HUMAN,PMGT1_RAT,PMGT1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000085998
    Target ClassificationN/A

    The target: POMGNT1, gene name: POMGNT1, also named as GNTI.2, GnT I.2, LGMD2O, LGMDR15, MEB, MGAT1.2, RP76, gnT-I.2. This gene encodes a type II transmembrane protein that resides in the Golgi apparatus. It participates in O-mannosyl glycosylation and is specific for alpha linked terminal mannose. Mutations in this gene may be associated with muscle-eye-brain disease and several congenital muscular dystrophies. Alternatively spliced transcript variants that encode different protein isoforms have been described. [provided by RefSeq, Feb 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.